Literature DB >> 31000416

CYP2D6 testing to guide risperidone and aripiprazole therapy.

Chad A Bousman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31000416     DOI： 10.1016/S2215-0366(19)30138-5

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  2 in total

1.  Antipsychotic Medications and DNA Methylation in Schizophrenia and Bipolar Disorder: A Systematic Review.

Authors:  Kyle J Burghardt; Audrey S Khoury; Zaher Msallaty; Zhengping Yi; Berhane Seyoum
Journal:  Pharmacotherapy       Date:  2020-03-09       Impact factor: 4.705

Review 2.  Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians' attitudes to sociocultural differences between patients across the globe.

Authors:  Justo Pinzón-Espinosa; Marte van der Horst; Janneke Zinkstok; Jehannine Austin; Cora Aalfs; Albert Batalla; Patrick Sullivan; Jacob Vorstman; Jurjen J Luykx
Journal:  Transl Psychiatry       Date:  2022-10-11       Impact factor: 7.989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.